LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system ...
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system ...
AngioDynamics' fiscal Q2'25 results exceeded expectations, with Med Tech growing 25% and delivering better gross margins, boosting confidence in achieving high single-digit revenue growth and ...
AngioDynamics, Inc. (ANGO) has revised its full-year adjusted loss outlook and now expects a narrower loss, amidst its strong second quarter performance. It also reiterated sales guidance for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results